Pinebridge Investments L.P. Acquires 8,241 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Pinebridge Investments L.P. increased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 27,549 shares of the company's stock after acquiring an additional 8,241 shares during the period. Pinebridge Investments L.P.'s holdings in HealthEquity were worth $2,643,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Pier Capital LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at approximately $8,024,000. HighTower Advisors LLC raised its stake in HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock valued at $9,122,000 after acquiring an additional 4,370 shares in the last quarter. Geneva Capital Management LLC boosted its position in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after acquiring an additional 206,894 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock worth $104,280,000 after purchasing an additional 25,004 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of HealthEquity by 4.7% during the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock valued at $11,988,000 after purchasing an additional 5,594 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HQY has been the subject of several research analyst reports. KeyCorp reduced their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. The Goldman Sachs Group decreased their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Finally, Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $111.75.

HealthEquity Trading Down 0.8 %

HQY traded down $0.70 during trading on Wednesday, reaching $85.72. The company had a trading volume of 722,092 shares, compared to its average volume of 774,453. The firm's 50-day simple moving average is $90.77 and its 200 day simple moving average is $96.51. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market cap of $7.41 billion, a price-to-earnings ratio of 78.64, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock valued at $1,781,432 over the last ninety days. Corporate insiders own 2.20% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.